Please Wait
Applying Filters...
menu
    • menu
    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    Veranova: A CDMO that manages complexity with confidence.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    An Enquiry

    Gangwal Healthcare is powered by innovation, driving health, wellness & healing.

    Virtual Booth

    Contact Supplier

    Aspen API. More than just an API™

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    An Enquiry

    Menu

    DEXTRAN SULFATE

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Enforcement Report - Week of April 8, 2026
    Enforcement Report - Week of April 8, 2026

    08 Apr 2026

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-april-8-2026-50375.pdf

    FDA
    08 Apr 2026
    Share Share
    Enforcement Report - Week of February 14, 2024
    Enforcement Report - Week of February 14, 2024

    14 Feb 2024

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-february-14-2024-75684.pdf

    FDA
    14 Feb 2024
    Share Share
    Enforcement Report - Week of November 29, 2023
    Enforcement Report - Week of November 29, 2023

    29 Nov 2023

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-november-29-2023-18805.pdf

    FDA
    29 Nov 2023
    Share Share
    Novartis's $90 million Swiss factory to help solve cell therapy bottleneck
    Novartis's $90 million Swiss factory to help solve cell therapy bottleneck

    01 Dec 2019

    // John Miller REUTERS

    https://www.reuters.com/article/us-novartis-swiss-factory/novartiss-90-million-swiss-factory-to-help-solve-cell-therapy-bottleneck-idUSKBN1Y214Y

    John Miller REUTERS
    01 Dec 2019
    Share Share
    Health Canada Issues Recall of Pfizer Canada ULC LMD 10% IN DEXTROSE 5%
    Health Canada Issues Recall of Pfizer Canada ULC LMD 10% IN DEXTROSE 5%

    26 Sep 2019

    // HEALTH CANADA

    https://www.pharmacompass.com/pdf/news/health-canada-issues-recall-of-pfizer-canada-ulc-lmd-10-in-dextrose-5-1569469093.pdf

    HEALTH CANADA
    26 Sep 2019
    Share Share
    Avedro Inc's Photrexa Viscous (Riboflavin 5 - Phosphate; Dextran) approved in US for treatment of Keratoconus
    Avedro Inc's Photrexa Viscous (Riboflavin 5 - Phosphate; Dextran) approved in US for treatment of Keratoconus

    15 Apr 2016

    // FDA

    https://www.pharmacompass.com/pdf/news/avedro-incs-photrexa-viscous-riboflavin-5-phosphate-dextran-approved-in-us-treatment-of-keratoconus-1461067032.pdf

    FDA
    15 Apr 2016
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.